Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06373978 · ClinicalTrials.gov registry record · Phase 4
NonNarcotic Pain Control in Percutaneous Needle Tenotomy of Elbow
A Phase 4 study of Chronic Pain and Elbow Pain, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 92
- Enrollment target
- 2
- Study locations
NCT06373978: Recruiting Phase 4 study of Chronic Pain and Elbow Pain, sponsored by The Cleveland Clinic.
NCT06373978 is a Phase 4 study of Chronic Pain and Elbow Pain that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 92 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06373978, a Phase 4 study of Chronic Pain and Elbow Pain, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 92 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is a double-blind, randomized controlled trial comparing the effectiveness of oral acetaminophen, diclofenac, and tramadol in reducing the consumption of narcotic doses (primary outcome) and minimizing patients' exposure to narcotics (secondary outcome) following an ultrasound-guided percutaneous needle tenotomy procedure on the lateral elbow.
Primary Outcome
The number of total Tramadol pills taken per patient between the control (Tramadol + Diclofenac rescue) vs experimental (Diclofenac + Tramadol rescue) groups at two weeks.
Conditions Studied
Interventions
- OTHER Acetaminophen
- DRUG Diclofenac
- DRUG Tramadol
Study Locations (2)
Florida
- The Cleveland Clinic Florida - Coral Springs
Ohio
- The Cleveland Clinic Ohio - Avon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2024-08-12 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 4 |
What NCT06373978 shows while recruiting
NCT06373978 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 3 interventions - of which Acetaminophen is the first listed.
NCT06373978 reports a single indexed study location in Florida, Ohio.
Frequently Asked Questions
What is clinical trial NCT06373978 about?
NCT06373978 is a clinical study titled "NonNarcotic Pain Control in Percutaneous Needle Tenotomy of Elbow". This study is a double-blind, randomized controlled trial comparing the effectiveness of oral acetaminophen, diclofenac, and tramadol in reducing the consumption of narcotic doses (primary outcome) and minimizing patients' exposure to narcotics (secondary outcome) following an ultrasound-guided perc...
What is the current status of trial NCT06373978?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 92 participants. The study started on 2024-08-12. Estimated completion is 2026-06-30.
What conditions does trial NCT06373978 study?
This clinical trial studies the following conditions: Chronic Pain, Elbow Pain.
What interventions are being tested in trial NCT06373978?
The interventions under investigation include: Acetaminophen (OTHER), Diclofenac (DRUG), Tramadol (DRUG).
Who is sponsoring clinical trial NCT06373978?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06373978 being conducted?
This trial has 2 study locations across Florida, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06373978's enrollment target sits among peer trials
92 144th of 301 higher than 158 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stanford Pragmatic Effectiveness Comparison
RECRUITING · Phase 4
-
Better Options for Chronic Cancer Pain
RECRUITING · Phase 4
-
Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department
RECRUITING · Phase 4
-
Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment
ACTIVE NOT RECRUITING · Phase 4
-
Propofol-Enhanced Assessment of Ketamine for Chronic Pain and Depression
ACTIVE NOT RECRUITING · Phase 4
-
PK Sampling After IV Oxytocin and Effects on Sensory Function in Healthy Volunteers
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI